4.4 Review

Identification of very small embryonic like (VSEL) stem cells in bone marrow

Journal

CELL AND TISSUE RESEARCH
Volume 331, Issue 1, Pages 125-134

Publisher

SPRINGER
DOI: 10.1007/s00441-007-0485-4

Keywords

Oct-4; Nanog; stage-specific embryonic antigen; G(alpha i)-protein-coupled seven transmembrane-spanning chemokine receptor; very small embryonic like stem cells; embryonic stem cells

Categories

Funding

  1. NCI NIH HHS [R01 CA106281-01] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA106281] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Bone marrow (BM) develops in mammals by the end of the second/beginning of the third trimester of gestation and becomes a major hematopoietic organ in postnatal life. The alpha-chemokine stromal derived factor-1 (SDF-1) to CXCR4 (G(alpha i)-protein-coupled seven transmembrane-spanning chemokine receptor) axis plays a major role in BM colonization by stem cells. By the end of the second trimester of gestation, BM becomes colonized by hematopoietic stem cells (HSC), which are chemoattracted from the fetal liver in a CXCR4-SDF-1-dependent manner. Whereas CXCR4 is expressed on HSC, SDF-1 is secreted by BM stroma and osteoblasts that line BM cavities. Mounting evidence indicates that BM also contains rare CXCR4(+) pluripotent stem cells (PSC). Recently, our group has identified a population of CXCR4(+) very small embryonic like stem cells in murine BM and human cord blood. We hypothesize that these cells are deposited during development in BM as a mobile pool of circulating PSC that play a pivotal role in postnatal tissue turnover, both of non-hematopoietic and hematopoietic tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available